Position in ABVX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$373,128
+$170,846 QoQ
Shares Held
2,800
+86.7% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.20%
of 13F equity value
Holder Rank
#213
of 301 holders
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in ABVX Over Time
Shares Held
Position Value (USD)
Derivatives in ABVX
reported options exposure · as of Jun 30, 2026CallValue
$0
CallShares
0
PutValue
$333,150
PutShares
2,500
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026HARVEST MANAGEMENT LLC holds $25,872,051 across 9 Biotechnology names. ABVX ranks #5 (1.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TECH |
BIO-TECHNE Corp
|
170,000 | $12,010,500 | |
| 2 | APGE |
Apogee Therapeutics, Inc.
|
79,000 | $10,485,670 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
7,221 | $1,352,348 | |
| 4 | CYTK |
Cytokinetics Inc
|
12,400 | $1,056,356 | |
| 5 | ABVX |
Abivax S.A.
This page
|
2,800 | $373,128 | |
| 6 | LGND |
Ligand Pharmaceuticals Inc
|
1,100 | $347,699 | |
| 7 | INBX |
Inhibrx Biosciences, Inc.
|
2,600 | $246,350 | |
| 8 | CPRX |
Catalyst Pharmaceuticals, Inc.
|
150,000 | $0 |
All Filings in ABVX
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $333,150 | 2,500 | Put | Other | 2026-08-14 | |
| 2026-06-30 | $373,128 | 2,800 | Shares | Other | 2026-08-14 | |
| 2025-12-31 | $202,282 | 1,500 | Shares | Other | 2026-02-17 | |
| No filing history on record for this holder in this stock. | ||||||